Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1147923

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1147923

Market Study on Biosimilars: Falling Product Prices to Supplement Market Growth

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7600
PDF (Corporate User License)
USD 10600

Add to Cart

Biosimilars Market: Report Scope

The latest market report by Persistence Market Research on the global biosimilars market evaluates the opportunities and current market scenario, providing insights and updates about corresponding segments involved in the market for the forecast period of 2022-2032. The report provides detailed assessment of key market dynamics, and comprehensive information about the structure of the market. This study contains detailed insights into how the market is anticipated to grow during the forecast period of 2022-2032.

The primary objective of the report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with biosimilars. It is very important to consider that, in an ever-wavering economy, we provide estimated (Y-o-Y) year-on-year growth rate in addition to compound annual growth rate (CAGR) for overall forecasts, to enable readers better understand the analysis and evaluation of the market, and to discover lucrative opportunities in this space.

This report also provides an estimate of market size and corresponding revenue forecasts carried out in terms of absolute $ opportunity. It also offers actionable insights based on the future trends in the market. Furthermore, new and emerging players in the global biosimilars market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global market.

The study is relevant for manufacturers, suppliers, distributors, and investors in the biosimilars market. All stakeholders, as well as industry experts, researchers, journalists, and business researchers can leverage the information and data represented in the report.

Key Market Segments

Persistence Market Research's report on the global biosimilars market offers information divided into four segments - product type, application, distribution channel, and region.

Product Type

Recombinant Glycosylated Proteins

Recombinant Non-Glycosylated Proteins

Application

Hematology

Growth Hormone Deficiency

Oncology

Diabetes Autoimmune

Disease

Others

Distribution Channel

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Region

North America

Latin America

Europe

South Asia and Pacific

East Asia

Middle East and Africa

Key Questions Answered in Study

Which region will hold the highest market share over the forecast period?

Which region is experiencing the highest growth (CAGR)?

Which factors are impacting the global biosimilars industry?

What are the global trends impacting the market?

What strategies must emerge players adopt to capture opportunities in various regions in the market?

What is the structure of the global biosimilars market?

Research Methodology

Persistence Market Research is committed to providing unbiased market research solutions to its clients. The company follows a robust methodology for the deduction of data included in this report. A unique research methodology is utilized to conduct extensive research on the global biosimilars market, and reach conclusions about the future growth factors of the market. The research methodology comprises primary research methods coupled with secondary research methods, which ensures the accuracy and reliability of the conclusions in this report.

A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period.

This methodology is based on standard market structures, methods, and definitions that are based on inputs from local sources in over six regions - North America, Latin America, Europe, South Asia and Pacific, East Asia, and the Middle East & Africa, which Persistence Market Research considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level, to create global market measurements.

Our main sources of research include:

Primary Research

Secondary Research

Trade Research

Social Media Research

Product Code: PMRREP2782

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic Promotional Strategies

5. Global Biosimilars Market Demand Analysis 2017-2021 and Forecast, 2022-2032

  • 5.1. Historical Market Volume (Tons) Analysis, 2017-2021
  • 5.2. Current and Future Market Volume (Tons) Projections, 2022-2032
  • 5.3. Y-o-Y Growth Trend Analysis

6. Global Biosimilars Market - Pricing Analysis

  • 6.1. Regional Pricing Analysis By Product Type
  • 6.2. Global Average Pricing Analysis Benchmark

7. Global Biosimilars Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Macro-Economic Factors
    • 8.1.1. Global GDP Growth Outlook
    • 8.1.2. Global Industry Value Added Overview
    • 8.1.3. Global Infrastructure Investment Overview
    • 8.1.4. Global Construction Spending Analysis
    • 8.1.5. Other Macro Economic Factors
  • 8.2. Forecast Factors - Relevance & Impact
    • 8.2.1. Top Companies Historical Growth
    • 8.2.2. GDP Growth forecast
    • 8.2.3. Construction Industry forecast
    • 8.2.4. Distribution Channel Growth Outlook
    • 8.2.5. Collaboration Activities
  • 8.3. Value Chain
    • 8.3.1. Raw Material Suppliers
    • 8.3.2. List of Manufacturers
    • 8.3.3. List of Distributors
  • 8.4. COVID-19 Crisis - Impact Assessment
    • 8.4.1. Current Statistics
    • 8.4.2. Short-Mid-Long Term Outlook
    • 8.4.3. Likely Rebound
  • 8.5. Market Dynamics
    • 8.5.1. Drivers
    • 8.5.2. Restraints
    • 8.5.3. Opportunity Analysis
    • 8.5.4. Trends

9. Global Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032, by Product Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis by Type, 2017-2021
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast by Product Type 2022-2032
    • 9.3.1. Recombinant Glycosylated Proteins
    • 9.3.2. Recombinant Non-Glycosylated Proteins
  • 9.4. Market Attractiveness Analysis by Product Type

10. Global Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2017-2021
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2022-2032
    • 10.3.1. Hematology
    • 10.3.2. Growth Hormone Deficiency
    • 10.3.3. Oncology
    • 10.3.4. Diabetes Autoimmune
    • 10.3.5. Disease
    • 10.3.6. Others
  • 10.4. Market Attractiveness Analysis By Application

11. Global Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume Analysis By Distribution Channel, 2017-2021
  • 11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Distribution Channel 2022-2032
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Online Pharmacies
    • 11.3.3. Retail Pharmacies
  • 11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2017-2021
  • 12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast by Region, 2022-2032
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia and Pacific
    • 12.3.6. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2017-2021
  • 13.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
    • 13.4.1. By Country
      • 13.4.1.1. U.S.
      • 13.4.1.2. Canada
    • 13.4.2. By Type
    • 13.4.3. By Application
    • 13.4.4. By Distribution Channel
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Type
    • 13.5.3. By Application
    • 13.5.4. By Distribution Channel
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2017-2021
  • 14.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
    • 14.4.1. By Country
      • 14.4.1.1. Brazil
      • 14.4.1.2. Mexico
      • 14.4.1.3. Rest of Latin America
    • 14.4.2. By Type
    • 14.4.3. By Application
    • 14.4.4. By Distribution Channel
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Type
    • 14.5.3. By Application
    • 14.5.4. By Distribution Channel
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Europe Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2017-2021
  • 15.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
    • 15.4.1. By Country
      • 15.4.1.1. Germany
      • 15.4.1.2. Italy
      • 15.4.1.3. France
      • 15.4.1.4. U.K.
      • 15.4.1.5. Spain
      • 15.4.1.6. BENELUX
      • 15.4.1.7. Russia
      • 15.4.1.8. Rest of Europe
    • 15.4.2. By Type
    • 15.4.3. By Application
    • 15.4.4. By Distribution Channel
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Type
    • 15.5.3. By Application
    • 15.5.4. By Distribution Channel
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. South Asia and Pacific Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2017-2021
  • 16.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
    • 16.4.1. By Country
      • 16.4.1.1. India
      • 16.4.1.2. ASEAN
      • 16.4.1.3. Oceania
      • 16.4.1.4. Rest of South Asia & Pacific
    • 16.4.2. By Type
    • 16.4.3. By Application
    • 16.4.4. By Distribution Channel
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Type
    • 16.5.3. By Application
    • 16.5.4. By Distribution Channel
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2017-2021
  • 17.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
    • 17.4.1. By Country
      • 17.4.1.1. China
      • 17.4.1.2. Japan
      • 17.4.1.3. South Korea
    • 17.4.2. By Type
    • 17.4.3. By Application
    • 17.4.4. By Distribution Channel
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Type
    • 17.5.3. By Application
    • 17.5.4. By Distribution Channel
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Biosimilars Market Analysis 2017-2021 and Forecast 2022-2032

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2017-2021
  • 18.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2022-2032
    • 18.4.1. By Country
      • 18.4.1.1. GCC Countries
      • 18.4.1.2. Turkey
      • 18.4.1.3. Northern Africa
      • 18.4.1.4. South Africa
      • 18.4.1.5. Rest of Middle East and Africa
    • 18.4.2. By Type
    • 18.4.3. By Application
    • 18.4.4. By Distribution Channel
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Type
    • 18.5.3. By Application
    • 18.5.4. By Distribution Channel
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Emerging Countries Biosimilars Market Analysis

  • 19.1. Introduction
    • 19.1.1. Market Value Proportion Analysis, By Key Countries
    • 19.1.2. Global Vs. Country Growth Comparison
  • 19.2. U.S. Biosimilars Market Analysis
    • 19.2.1. By Type
    • 19.2.2. By Application
    • 19.2.3. By Distribution Channel
  • 19.3. Canada Biosimilars Market Analysis
    • 19.3.1. By Type
    • 19.3.2. By Application
    • 19.3.3. By Distribution Channel
  • 19.4. Mexico Biosimilars Market Analysis
    • 19.4.1. By Type
    • 19.4.2. By Application
    • 19.4.3. By Distribution Channel
  • 19.5. Brazil Biosimilars Market Analysis
    • 19.5.1. By Type
    • 19.5.2. By Application
    • 19.5.3. By Distribution Channel
  • 19.6. Germany Biosimilars Market Analysis
    • 19.6.1. By Type
    • 19.6.2. By Application
    • 19.6.3. By Distribution Channel
  • 19.7. Italy Biosimilars Market Analysis
    • 19.7.1. By Type
    • 19.7.2. By Application
    • 19.7.3. By Distribution Channel
  • 19.8. France Biosimilars Market Analysis
    • 19.8.1. By Type
    • 19.8.2. By Application
    • 19.8.3. By Distribution Channel
  • 19.9. U.K. Biosimilars Market Analysis
    • 19.9.1. By Type
    • 19.9.2. By Application
    • 19.9.3. By Distribution Channel
  • 19.10. Spain Biosimilars Market Analysis
    • 19.10.1. By Type
    • 19.10.2. By Application
    • 19.10.3. By Distribution Channel
  • 19.11. BENELUX Biosimilars Market Analysis
    • 19.11.1. By Type
    • 19.11.2. By Application
    • 19.11.3. By Distribution Channel
  • 19.12. Russia Biosimilars Market Analysis
    • 19.12.1. By Type
    • 19.12.2. By Application
    • 19.12.3. By Distribution Channel
  • 19.13. China Biosimilars Market Analysis
    • 19.13.1. By Type
    • 19.13.2. By Application
    • 19.13.3. By Distribution Channel
  • 19.14. Japan Biosimilars Market Analysis
    • 19.14.1. By Type
    • 19.14.2. By Application
    • 19.14.3. By Distribution Channel
  • 19.15. S. Korea Biosimilars Market Analysis
    • 19.15.1. By Type
    • 19.15.2. By Application
    • 19.15.3. By Distribution Channel
  • 19.16. India Biosimilars Market Analysis
    • 19.16.1. By Type
    • 19.16.2. By Application
    • 19.16.3. By Distribution Channel
  • 19.17. ASEAN Biosimilars Market Analysis
    • 19.17.1. By Type
    • 19.17.2. By Application
    • 19.17.3. By Distribution Channel
  • 19.18. Australia and New Zealand Biosimilars Market Analysis
    • 19.18.1. By Type
    • 19.18.2. By Application
    • 19.18.3. By Distribution Channel
  • 19.19. GCC Countries Biosimilars Market Analysis
    • 19.19.1. By Type
    • 19.19.2. By Application
    • 19.19.3. By Distribution Channel
  • 19.20. Turkey Biosimilars Market Analysis
    • 19.20.1. By Type
    • 19.20.2. By Application
    • 19.20.3. By Distribution Channel
  • 19.21. Northern Africa Biosimilars Market Analysis
    • 19.21.1. By Type
    • 19.21.2. By Application
    • 19.21.3. By Distribution Channel
  • 19.22. South Africa Biosimilars Market Analysis
    • 19.22.1. By Type
    • 19.22.2. By Application
    • 19.22.3. By Distribution Channel

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies (Linear Alpha-Olefins)
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Pfizer Inc.
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
    • 21.3.2. Sandoz International GMBH
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
    • 21.3.3. Eli Lily & Company
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
    • 21.3.4. Hospira Inc.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
    • 21.3.5. Amgen, Inc.
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
    • 21.3.6. Biocon Ltd.
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
    • 21.3.7. Actavis, Inc.
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
    • 21.3.8. Cipla Ltd.
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
    • 21.3.9. Teva Pharmaceutical Industries, Ltd.
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
    • 21.3.10. Dr. Reddy's Laboratories Ltd.
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
    • 21.3.11. Celltrion, Inc.
      • 21.3.11.1. Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.11.4. Sales Footprint
      • 21.3.11.5. Strategy Overview
    • 21.3.12. Stada Arzeimittel Ag
      • 21.3.12.1. Overview
      • 21.3.12.2. Product Portfolio
      • 21.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.12.4. Sales Footprint
      • 21.3.12.5. Strategy Overview
    • 21.3.13. Mylan, Inc.
      • 21.3.13.1. Overview
      • 21.3.13.2. Product Portfolio
      • 21.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.13.4. Sales Footprint
      • 21.3.13.5. Strategy Overview
    • 21.3.14. Wockhardt Ltd.
      • 21.3.14.1. Overview
      • 21.3.14.2. Product Portfolio
      • 21.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.14.4. Sales Footprint
      • 21.3.14.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Product Code: PMRREP2782

List of Tables

  • Table 01: Global Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Product Type, 2017- 2032
  • Table 02: Global Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Application, 2017- 2032
  • Table 03: Global Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Distribution Channel, 2017- 2032
  • Table 04: Global Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Region, 2017- 2032
  • Table 05: North America Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Country, 2017- 2032
  • Table 06: North America Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Product Type, 2017- 2032
  • Table 07: North America Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Application, 2017- 2032
  • Table 08: North America Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Distribution Channel, 2017- 2032
  • Table 09: Latin America Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Country, 2017- 2032
  • Table 10: Latin America Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Product Type, 2017- 2032
  • Table 11: Latin America Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Application, 2017- 2032
  • Table 12: Latin America Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Distribution Channel, 2017- 2032
  • Table 13: Europe Biosimilars Market Volume ('000 Units) Forecast by Country 2017- 2032
  • Table 14: Europe Biosimilars Market Value(US $ Mn) Forecast by Country, 2017- 2032
  • Table 15: Europe Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Product Type, 2017- 2032
  • Table 16: Europe Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Application, 2017- 2032
  • Table 17: Europe Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Distribution Channel, 2017- 2032
  • Table 18: South Asia & Pacific Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Country,2017- 2032
  • Table 19: South Asia & Pacific Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Product Type, 2017- 2032
  • Table 20: South Asia & Pacific Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Application, 2017- 2032
  • Table 21: South Asia & Pacific Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Distribution Channel, 2017- 2032
  • Table 22: East Asia Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Country, 2017- 2032
  • Table 23: East Asia Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Product Type, 2017- 2032
  • Table 24: East Asia Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Application, 2017- 2032
  • Table 25: East Asia Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Distribution Channel, 2017- 2032
  • Table 26: Middle East & Africa Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Country, 2017- 2032
  • Table 27: Middle East & Africa Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Product Type, 2017- 2032
  • Table 28: Middle East & Africa Biosimilars Market Volume ('000 Units) & Value (US$ Mn) Forecast by Application, 2017- 2032
  • Table 29: Middle East & Africa Biosimilars Market Volume ('000 Units) & Value(US$ Mn) Forecast by Distribution Channel, 2017- 2032

List of Figures

  • Figure 01: Global Biosimilars Market Historical Volume ('000 Units), 2017 - 2021
  • Figure 02: Global Biosimilars Market Volume ('000 Units) Forecast, 2022 - 2032
  • Figure 03: Global Biosimilars Market Size (2017-2021)
  • Figure 04: Global Biosimilars Absolute $ Opportunity Analysis (2017-2032)
  • Figure 05: Global Biosimilars Market Size (2022-2032)
  • Figure 06: Global Biosimilars Market BPS Analysis by Product Type- 2022 & 2032
  • Figure 07: Global Biosimilars Market Y-o-Y Growth by Product Type, 2021- 2032
  • Figure 08: Global Biosimilars Market Attractiveness Analysis by Product Type, 2022- 2032
  • Figure 09: Global Biosimilars Market BPS Analysis by Application- 2022 & 2032
  • Figure 10: Global Biosimilars Market Y-o-Y Growth by Application, 2021- 2032
  • Figure 11: Global Biosimilars Market Attractiveness Analysis by Application, 2022- 2032
  • Figure 12: Global Biosimilars Market BPS Analysis by Distribution Channel- 2022 & 2032
  • Figure 13: Global Biosimilars Market Y-o-Y Growth by Distribution Channel, 2021- 2032
  • Figure 14: Global Biosimilars Market Attractiveness Analysis by Distribution Channel, 2022- 2032
  • Figure 15: Global Biosimilars Market BPS Analysis by Region- 2022 & 2032
  • Figure 16: Global Biosimilars Market Y-o-Y Growth by Region, 2021- 2032
  • Figure 17: Global Biosimilars Market Attractiveness Analysis by Region, 2022- 2032
  • Figure 18: North America Biosimilars Market BPS Analysis by Country- 2022 & 2032
  • Figure 19: North America Biosimilars Market Y-o-Y Growth by Country, 2021- 2032
  • Figure 20: North America Biosimilars Market Attractiveness Analysis by Country, 2022- 2032
  • Figure 21: North America Biosimilars Market BPS Analysis by Product Type- 2022 & 2032
  • Figure 22: North America Biosimilars Market Y-o-Y Growth by Product Type, 2021- 2032
  • Figure 23: North America Biosimilars Market Attractiveness Analysis by Product Type, 2022- 2032
  • Figure 24: North America Biosimilars Market BPS Analysis by Application- 2022 & 2032
  • Figure 25: North America Biosimilars Market Y-o-Y Growth by Application, 2021- 2032
  • Figure 26: North America Biosimilars Market Attractiveness Analysis by Application, 2022- 2032
  • Figure 27: North America Biosimilars Market BPS Analysis by Distribution Channel- 2022 & 2032
  • Figure 28: North America Biosimilars Market Y-o-Y Growth by Distribution Channel, 2021- 2032
  • Figure 29: North America Biosimilars Market Attractiveness Analysis by Distribution Channel, 2022- 2032
  • Figure 30: Latin America Biosimilars Market BPS Analysis by Country- 2022 & 2032
  • Figure 31: Latin America Biosimilars Market Y-o-Y Growth by Country, 2021- 2032
  • Figure 32: Latin America Biosimilars Market Attractiveness Analysis by Country, 2022- 2032
  • Figure 33: Latin America Biosimilars Market BPS Analysis by Product Type- 2022 & 2032
  • Figure 34: Latin America Biosimilars Market Y-o-Y Growth by Product Type, 2021- 2032
  • Figure 35: Latin America Biosimilars Market Attractiveness Analysis by Product Type, 2022- 2032
  • Figure 36: Latin America Biosimilars Market BPS Analysis by Application- 2022 & 2032
  • Figure 37: Latin America Biosimilars Market Y-o-Y Growth by Application, 2021- 2032
  • Figure 38: Latin America Biosimilars Market Attractiveness Analysis by Application, 2022- 2032
  • Figure 39: Latin America Biosimilars Market BPS Analysis by Distribution Channel- 2022 & 2032
  • Figure 40: Latin America Biosimilars Market Y-o-Y Growth by Distribution Channel, 2021- 2032
  • Figure 41: Latin America Biosimilars Market Attractiveness Analysis by Distribution Channel, 2022- 2032
  • Figure 42: Europe Biosimilars Market BPS Analysis by Country- 2022 & 2032
  • Figure 43: Europe Biosimilars Market Y-o-Y Growth by Country, 2021- 2032
  • Figure 44: Europe Biosimilars Market Attractiveness Analysis by Country, 2022- 2032
  • Figure 45: Europe Biosimilars Market BPS Analysis by Product Type- 2022 & 2032
  • Figure 46: Europe Biosimilars Market Y-o-Y Growth by Product Type, 2021- 2032
  • Figure 47: Europe Biosimilars Market Attractiveness Analysis by Product Type, 2022- 2032
  • Figure 48: Europe Biosimilars Market BPS Analysis by Application- 2022 & 2032
  • Figure 49: Europe Biosimilars Market Y-o-Y Growth by Application, 2021- 2032
  • Figure 50: Europe Biosimilars Market Attractiveness Analysis by Application, 2022- 2032
  • Figure 51: Europe Biosimilars Market BPS Analysis by Distribution Channel- 2022 & 2032
  • Figure 52: Europe Biosimilars Market Y-o-Y Growth by Distribution Channel, 2021- 2032
  • Figure 53: Europe Biosimilars Market Attractiveness Analysis by Distribution Channel, 2022- 2032
  • Figure 54: South Asia & Pacific Biosimilars Market BPS Analysis by Country- 2022 & 2032
  • Figure 55: South Asia & Pacific Biosimilars Market Y-o-Y Growth by Country, 2021- 2032
  • Figure 56: South Asia & Pacific Biosimilars Market Attractiveness Analysis by Country, 2022- 2032
  • Figure 57: South Asia & Pacific Biosimilars Market BPS Analysis by Product Type- 2022 & 2032
  • Figure 58: South Asia & Pacific Biosimilars Market Y-o-Y Growth by Product Type, 2021- 2032
  • Figure 59: South Asia & Pacific Biosimilars Market Attractiveness Analysis by Product Type, 2022- 2032
  • Figure 60: South Asia & Pacific Biosimilars Market BPS Analysis by Application- 2022 & 2032
  • Figure 61: South Asia & Pacific Biosimilars Market Y-o-Y Growth by Application, 2021- 2032
  • Figure 62: South Asia & Pacific Biosimilars Market Attractiveness Analysis by Application, 2022- 2032
  • Figure 63: South Asia & Pacific Biosimilars Market BPS Analysis by Distribution Channel- 2022 & 2032
  • Figure 64: South Asia & Pacific Biosimilars Market Y-o-Y Growth by Distribution Channel, 2021- 2032
  • Figure 65: South Asia & Pacific Biosimilars Market Attractiveness Analysis by Distribution Channel, 2022- 2032
  • Figure 66: East Asia Biosimilars Market BPS Analysis by Country- 2022 & 2032
  • Figure 67: East Asia Biosimilars Market Y-o-Y Growth by Country, 2021- 2032
  • Figure 68: East Asia Biosimilars Market Attractiveness Analysis by Country, 2022- 2032
  • Figure 69: East Asia Biosimilars Market BPS Analysis by Product Type- 2022 & 2032
  • Figure 70: East Asia Biosimilars Market Y-o-Y Growth by Product Type, 2021- 2032
  • Figure 71: East Asia Biosimilars Market Attractiveness Analysis by Product Type, 2022- 2032
  • Figure 72: East Asia Biosimilars Market BPS Analysis by Application- 2022 & 2032
  • Figure 73: East Asia Biosimilars Market Y-o-Y Growth by Application, 2021- 2032
  • Figure 74: East Asia Biosimilars Market Attractiveness Analysis by Application, 2022- 2032
  • Figure 75: East Asia Biosimilars Market BPS Analysis by Distribution Channel- 2022 & 2032
  • Figure 76: East Asia Biosimilars Market Y-o-Y Growth by Distribution Channel, 2021- 2032
  • Figure 77: East Asia Biosimilars Market Attractiveness Analysis by Distribution Channel, 2022- 2032
  • Figure 78: Middle East & Africa Biosimilars Market BPS Analysis by Country- 2022 & 2032
  • Figure 79: Middle East & Africa Biosimilars Market Y-o-Y Growth by Country, 2021- 2032
  • Figure 80: Middle East & Africa Biosimilars Market Attractiveness Analysis by Country, 2022- 2032
  • Figure 81: Middle East & Africa Biosimilars Market BPS Analysis by Product Type- 2022 & 2032
  • Figure 82: Middle East & Africa Biosimilars Market Y-o-Y Growth by Product Type, 2021- 2032
  • Figure 83: Middle East & Africa Biosimilars Market Attractiveness Analysis by Product Type, 2022- 2032
  • Figure 84: Middle East & Africa Biosimilars Market BPS Analysis by Application- 2022 & 2032
  • Figure 85: Middle East & Africa Biosimilars Market Y-o-Y Growth by Application, 2021- 2032
  • Figure 86: Middle East & Africa Biosimilars Market Attractiveness Analysis by Application, 2022- 2032
  • Figure 87: Middle East & Africa Biosimilars Market BPS Analysis by Distribution Channel- 2022 & 2032
  • Figure 88: Middle East & Africa Biosimilars Market Y-o-Y Growth by Distribution Channel, 2021- 2032
  • Figure 89: Middle East & Africa Biosimilars Market Attractiveness Analysis by Distribution Channel, 2022- 2032
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!